Skip to main content
Caplight Logo









Prothegen Inc.

Prothegen Inc.

Private
Stanford, CaliforniaHealthcare & Life Scienceshttps://prothegen.com

Last Round

Accelerator

Jan 1, 2022

Company Overview

Prothegen Inc. operates in Healthcare & Life Sciences and is based in Stanford, California. Its latest recorded funding round was an Accelerator round in January 2022.

Prothegen Inc. is a biotechnology company that develops a platform to precisely regulate cell death by targeting ferroptosis for the treatment of various diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Prothegen Inc. Comparables

Compare Prothegen Inc. with similar companies based on industry and business-model similarity.

Prothegen Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Exarta Therapeutics
90%
Kojin Therapeutics
87%
ProJenX, Inc.
78%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Prothegen Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorJan 1, 2022
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Prothegen Inc. Investors

Notable investors and investment history

Prothegen Inc. investors
InvestorRounds
SOSVAccelerator

Prothegen Inc. Filings

Explore SEC and related filing metadata, where available.

Prothegen Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Prothegen Inc.'s valuation, stock price, and market status.

Is Prothegen Inc. a public or private company?

Prothegen Inc. is a private company.

What is the current stock price of Prothegen Inc.?

Prothegen Inc. is a private company, so its shares have no public market price. Caplight tracks Prothegen Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Prothegen Inc. worth (valuation)?

Valuation information for Prothegen Inc. is not publicly available.

Can I buy Prothegen Inc. stock?

Prothegen Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Prothegen Inc.'s last funding round?

Prothegen Inc.'s most recent funding round was Accelerator on January 1, 2022.

Who are the main investors in Prothegen Inc.?

Key investors in Prothegen Inc. include SOSV.

Will Prothegen Inc. IPO soon?

No public IPO plans have been announced for Prothegen Inc..

How can I track Prothegen Inc. secondary market activity?

Caplight tracks bids, offers, and trades in Prothegen Inc.'s shares on secondary markets.

Firmographic Details

HeadquartersStanford, California
Year Founded2021
Last FundingJan 1, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?